Search
for
Sort by
Research 661–690 of 1000+
- Androgenetic alopecia risk in allergic rhinitis: A cohort study of immune and antihistamine effects
- CXCL12 Drives Reversible Fibroimmune Remodeling in Androgenetic Alopecia Revealed by Single-Cell RNA Sequencing
- The Involvement of RIPK1 in Alopecia Areata
- Biologic: A Double Edged Sword - A Case of Etanercept Induced Alopecia Areata in a Patient with Psoriasis Vulgaris
- Perifollicular Inflammation and Fibrosis in Androgenetic Alopecia: Implications for Diagnosis and Treatment - A Comparative Histopathologic and Clinical Study with Normal-Appearing Scalp
- Saw palmetto extract: A dermatologist's perspective
- Laser Treatment in Hirsutism: An Update
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Efficacy of derinat as a treatment for murine and androgenetic alopecia (AGA) patients
- Melatonin: functions and ligands
- Autoimmune Disease Induction in a Healthy Human Organ: A Humanized Mouse Model of Alopecia Areata
- JAK Inhibitors for Treatment of Alopecia Areata
- Dissolving microneedles: Applications and growing therapeutic potential
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- Activity of 17β-(N-Alkyl/arylformamido) and 17β-[(N-Alkyl/aryl) alkyl/arylamido]-4-methyl-4-aza-5α-androstan-3-ones as 5α-Reductase Inhibitors in the Hamster Flank Organ and Ear11The research has been supported by Endorecherche that is seeking patent protection for the new compounds. F. Labrie is President of Endorecherche.
- Single‐cell transcriptomics reveals a senescence‐associated IL ‐6/ CCR6 axis driving radiodermatitis
- Oral Lichen Planus
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Large-Scale Plasma Proteomics and Genetic Integration Uncover Novel Biological Pathways in Male Pattern Baldness
- The Dickkopf Protein Family in Non-Neoplastic Disorders: Emerging Roles and Therapeutic Targeting
- Pathogenic variants affecting peptidyl arginine deiminase 3 and its major substrates underlie central centrifugal cicatricial alopecia
- Case Report: A novel KRT74 variant in an eight-year-old boy with alopecia totalis successfully treated with baricitinib
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Advances in Chitosan-Based Nanoparticles for Drug Delivery
- Age-associated inflammation connects RAS-induced senescence to stem cell dysfunction and epidermal malignancy
- Lysophospholipid Mediators in Health and Disease
- Protective Role of Melatonin and Its Metabolites in Skin Aging
- Vitamin D and the Parenteral Nutrition Patient